NCT07073183
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT07073183
Title Safety and Tolerability of CVHNLC Plus Pembrolizumab in Patients With Squamous Non Small-Cell Lung Cancer (sqNSCLC)
Recruitment Not yet recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors CureVac
Indications
Therapies
Age Groups: senior | adult
Covered Countries USA | FRA | ESP

Facility Status City State Zip Country Details
Virginia Cancer Center Fairfax Virginia 22031 United States Details
Virginia Commonwealth University, Massey Comprehensive Cancer Center, McGlothlin Medical Education Center Richmond Virginia 23298 United States Details
AP-HM - Hôpital Nord Marseille France Details
Institut Curie - Hôpital de Paris Paris France Details
CHU de Rennes - Hôpital Pontchaillou Rennes France Details
Institut de Cancerologie de l'Ouest - Hôpital Saint Herblain - PPDS Saint-Herblain France Details
Institut Claudius Regaud - PPDS Toulouse France Details
Gustave Roussy Villejuif France Details
Hospital Quironsalud Barcelona -NEXT Oncology Barcelona Spain Spain Details
Hospital Universitari Vall d´Hebron -Instituto de Investigacion Oncologica Vall dHebron (VHIO) Barcelona Spain Spain Details
Hospital Universitario Fundacion Jimenez Diaz - START MADRID Madrid Spain Spain Details
Hospital Universitario HM Sanchinarro - CIOCC - START MADRID Madrid Spain Spain Details
Hospital Regional Universitario Virgen de la Victoria Málaga Spain Spain Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field